ADMA logo

ADMA Biologics (ADMA) Cash and cash equivalents

annual cash & cash equivalents:

$103.15M+$51.80M(+100.86%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADMA annual cash & cash equivalents is $103.15 million, with the most recent change of +$51.80 million (+100.86%) on December 31, 2024.
  • During the last 3 years, ADMA annual cash & cash equivalents has risen by +$52.06 million (+101.90%).
  • ADMA annual cash & cash equivalents is now at all-time high.

Performance

ADMA Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAbalance sheet metrics

quarterly cash & cash equivalents:

$71.63M-$31.52M(-30.56%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADMA quarterly cash & cash equivalents is $71.63 million, with the most recent change of -$31.52 million (-30.56%) on March 31, 2025.
  • Over the past year, ADMA quarterly cash & cash equivalents has increased by +$26.30 million (+58.03%).
  • ADMA quarterly cash & cash equivalents is now -30.56% below its all-time high of $103.15 million, reached on December 31, 2024.

Performance

ADMA quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ADMA Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+100.9%+58.0%
3 y3 years+101.9%+3.0%
5 y5 years+285.6%-29.3%

ADMA Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+101.9%-30.6%+105.2%
5 y5-yearat high+285.6%-30.6%+108.2%
alltimeall timeat high>+9999.0%-30.6%>+9999.0%

ADMA Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$71.63M(-30.6%)
Dec 2024
$103.15M(+100.9%)
$103.15M(+19.0%)
Sep 2024
-
$86.71M(-1.7%)
Jun 2024
-
$88.24M(+94.7%)
Mar 2024
-
$45.33M(-11.7%)
Dec 2023
$51.35M(-40.6%)
$51.35M(-30.8%)
Sep 2023
-
$74.16M(+18.6%)
Jun 2023
-
$62.51M(-9.7%)
Mar 2023
-
$69.20M(-20.0%)
Dec 2022
$86.52M(+69.4%)
$86.52M(+147.9%)
Sep 2022
-
$34.91M(-33.4%)
Jun 2022
-
$52.42M(-24.6%)
Mar 2022
-
$69.50M(+36.0%)
Dec 2021
$51.09M(-8.6%)
$51.09M(+48.5%)
Sep 2021
-
$34.41M(-18.9%)
Jun 2021
-
$42.41M(-31.6%)
Mar 2021
-
$61.97M(+10.8%)
Dec 2020
$55.92M(+109.0%)
$55.92M(-6.3%)
Sep 2020
-
$59.67M(-21.3%)
Jun 2020
-
$75.78M(-25.1%)
Mar 2020
-
$101.24M(+278.4%)
Dec 2019
$26.75M(+17.6%)
$26.75M(-44.3%)
Sep 2019
-
$48.01M(-34.8%)
Jun 2019
-
$73.62M(+345.2%)
Mar 2019
-
$16.53M(-27.3%)
Dec 2018
$22.75M(-47.2%)
$22.75M(-46.3%)
Sep 2018
-
$42.37M(-23.2%)
Jun 2018
-
$55.15M(+111.2%)
Mar 2018
-
$26.12M(-39.4%)
Dec 2017
$43.11M
$43.11M(+216.9%)
DateAnnualQuarterly
Sep 2017
-
$13.60M(-46.8%)
Jun 2017
-
$25.57M(+199.4%)
Mar 2017
-
$8.54M(-13.8%)
Dec 2016
$9.91M(-5.0%)
$9.91M(+25.4%)
Sep 2016
-
$7.91M(-37.0%)
Jun 2016
-
$12.55M(+40.6%)
Mar 2016
-
$8.93M(-14.5%)
Dec 2015
$10.44M(-39.3%)
$10.44M(+13.8%)
Sep 2015
-
$9.18M(+17.3%)
Jun 2015
-
$7.82M(-52.8%)
Mar 2015
-
$16.56M(-3.7%)
Dec 2014
$17.20M(-34.2%)
$17.20M(+23.3%)
Sep 2014
-
$13.95M(-21.9%)
Jun 2014
-
$17.87M(-32.6%)
Mar 2014
-
$26.52M(+1.4%)
Dec 2013
$26.15M(+108.6%)
$26.15M(+386.1%)
Sep 2013
-
$5.38M(-29.7%)
Jun 2013
-
$7.65M(-25.8%)
Mar 2013
-
$10.32M(-17.7%)
Dec 2012
$12.54M(>+9900.0%)
$12.54M(+16.9%)
Sep 2012
-
$10.72M(-16.8%)
Jun 2012
-
$12.89M(-9.5%)
Mar 2012
-
$14.24M(>+9900.0%)
Dec 2011
-
$8100.00(+37.3%)
Sep 2011
-
$5900.00(-30.6%)
Jun 2011
$8500.00(-29.2%)
$8500.00(-47.5%)
Mar 2011
-
$16.20K(+422.6%)
Dec 2010
-
$3100.00(-74.2%)
Jun 2010
-
$12.00K
Jun 2010
$12.00K
-

FAQ

  • What is ADMA Biologics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for ADMA Biologics?
  • What is ADMA Biologics annual cash & cash equivalents year-on-year change?
  • What is ADMA Biologics quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for ADMA Biologics?
  • What is ADMA Biologics quarterly cash & cash equivalents year-on-year change?

What is ADMA Biologics annual cash & cash equivalents?

The current annual cash & cash equivalents of ADMA is $103.15M

What is the all time high annual cash & cash equivalents for ADMA Biologics?

ADMA Biologics all-time high annual cash & cash equivalents is $103.15M

What is ADMA Biologics annual cash & cash equivalents year-on-year change?

Over the past year, ADMA annual cash & cash equivalents has changed by +$51.80M (+100.86%)

What is ADMA Biologics quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of ADMA is $71.63M

What is the all time high quarterly cash & cash equivalents for ADMA Biologics?

ADMA Biologics all-time high quarterly cash & cash equivalents is $103.15M

What is ADMA Biologics quarterly cash & cash equivalents year-on-year change?

Over the past year, ADMA quarterly cash & cash equivalents has changed by +$26.30M (+58.03%)
On this page